Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Prilocaine
Synonyms :
prilocaine
Class :
Local anesthetics, Dental, Amides
Dosage Forms & StrengthsÂ
Injectable solutionÂ
4%Â
4% with 1:200,000 epinephrineÂ
Local Anesthetics:
prilocaine 4% solution or prilocaine combined with epinephrine, 40 to 80 mg (1-2 mL), for dental infiltration
Do not exceed (8 mg/kg) 600 mg in two hours
Dosage Forms & StrengthsÂ
Injectable solutionÂ
4%Â
4% with 1:200,000 epinephrineÂ
Local Anesthetics:
<10 years: Dental infiltration: 40 mg of a 4% solution in a 1 mL dose. Do not exceed 8 mg/kg in 2 hours
More than 10 years:
Dental infiltration: 40 to 80 mg (1 to 2 mL) of prilocaine in combination or prilocaine with epinephrine in a 4% solution.
Do not exceed 600 mg (8 mg/kg) in a two-hour period.
Refer adult dosingÂ
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of local anesthetics
may have an increasingly adverse effect when combined with prilocaine
may have an increasingly adverse effect when combined with prilocaine
may have an increasingly adverse effect when combined with prilocaine
may have an increasingly adverse effect when combined with prilocaine
may have an increasingly adverse effect when combined with prilocaine
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of Local Anesthetics
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the toxic effect of Methemoglobinemia Associated Agents
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the toxic effect of Methemoglobinemia Associated Agents
When cyclacillin is used together with prilocaine, this leads to increased risk or seriousness of methemoglobinemia
may increase the toxic effect
may increase the adverse effect of Methemoglobinemia Associated Agents
may increase the adverse effect of Methemoglobinemia Associated Agents
the risk of methemoglobinemia may be increased
the risk of methemoglobinemia may be increased
the risk of methemoglobinemia can be increased
the risk of methemoglobinemia may be increased
Actions and Spectrum:Â
Frequency not definedÂ
ApprehensionÂ
NervousnessÂ
ConfusionÂ
Blurred visionÂ
TwitchingÂ
SeizuresÂ
EdemaÂ
Status asthmaticusÂ
Anaphylactoid reactions (sometimes fatal)Â
AnxietyÂ
RestlessnessÂ
DisorientationÂ
DizzinessÂ
TremorsÂ
ShiveringÂ
Contraindications/caution:Â
Contraindications:Â
Caution:Â
Pregnancy consideration: prilocaine should be used cautiously in pregnant womenÂ
Pregnancy Category: CÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Pharmacology:Â
prilocaine is a local anesthetic of the amide-type. It reversibly blocks nerve impulse transmission by inhibiting sodium ion influx through sodium-specific ion channels in the neuronal membrane. This prevents pain signals from being transmitted to the brain, resulting in numbness and reduced sensation in the area where the drug is applied.Â
Pharmacodynamics:Â
The pharmacodynamics of prilocaine involve its mechanism of action in the nervous system, specifically the blockade of voltage-gated sodium channels in neuronal membranes, which leads to the inhibition of nerve impulse transmission.Â
As a local anesthetic, prilocaine selectively blocks the sodium channels in the nerve fibers of the tissue where it is administered. This prevents the initiation and propagation of action potentials in the nerve fibers, thus inhibiting the transmission of pain signals from the application site to the central nervous system.Â
Pharmacokinetics:Â
AbsorptionÂ
prilocaine is rapidly absorbed after injection or topical application. Adding vasoconstrictors, such as epinephrine, can delay the absorption and prolong the duration of action.Â
DistributionÂ
prilocaine is moderately protein-bound (approximately 55%) and has a relatively small volume of distribution (0.6-4.4 L/kg). The onset of action of prilocaine depends on the mode of administration and the application site. For example, infiltration anesthesia typically lasts 2 minutes, while an inferior alveolar nerve block may take up to 3 minutes to take effect. Â
MetabolismÂ
prilocaine is primarily metabolized in the liver, and to a lesser extent, in the kidneys, by the enzyme CYP1A2. It is converted to ortho-toluidine, which can cause methemoglobinemia in high doses.Â
Elimination and ExcretionÂ
prilocaine and its metabolites are primarily eliminated through the kidneys, with approximately 10% of the drug being excreted unchanged in the urine. The half-life of prilocaine is approximately 10-150 minutes, depending on the dose and route of administration.Â
Administration:Â
prilocaine is primarily administered via injection, either as a subcutaneous or intramuscular injection, depending on the intended use and site of application. It is also available as a topical cream or gel for surface anesthesia. The specific administration method and dosage of prilocaine will depend on the intended use and the patient’s needs.Â
For dental procedures, prilocaine is often administered as a local anesthetic by injection directly into the gum or around the affected tooth. The dosage will depend on the patient’s weight, age, and severity of the pain. The medication may be administered directly into the affected tissue or muscle in surgical procedures.Â
Patient information leafletÂ
Generic Name: prilocaineÂ
Why do we use prilocaine?Â
prilocaine is a local anesthetic medication primarily used for its numbing effects. It is commonly used in various medical and dental procedures to reduce pain and discomfort, such as:Â